(OLPX) Olaplex Holdings - Overview
Sector: Consumer Cyclical | Industry: Specialty Retail | Exchange: NASDAQ (USA) | Market Cap: 1.378m USD | Total Return: 60.6% in 12m
Avg Turnover: 6.11M
EPS Trend: -95.6%
Qual. Beats: 1
Rev. Trend: -81.9%
Qual. Beats: 1
Warnings
Interest Coverage Ratio 0.3 is critical
Fakeout
Tailwinds
Rs Leader, Idiosyncratic Leader, Tailwind
Olaplex Holdings, Inc. (OLPX) is a prestige haircare company that specializes in scientifically developed products designed to repair, maintain, and protect hair health. Founded in 2014 and headquartered in New York, the firm operates within the Consumer Staples sector, focusing on the Personal Care Products sub-industry. Its portfolio includes shampoos, conditioners, treatments, and serums marketed for both professional and consumer use.
The company utilizes an omni-channel distribution strategy, reaching customers through professional salons, specialty retailers, and direct-to-consumer e-commerce platforms. This hybrid model allows the brand to leverage professional endorsements to drive retail demand, a common strategy in the high-end beauty sector where salon-grade credibility serves as a primary marketing tool. The prestige beauty market is characterized by high brand loyalty and significant reliance on proprietary chemical formulations or patents to maintain a competitive advantage.
Investors seeking deeper insights into the companys valuation metrics may find further clarity by exploring the data on ValueRay. As a small-cap entity listed on the NASDAQ since its 2021 IPO, Olaplex remains subject to the volatility and shifting consumer trends inherent in the global beauty and personal care landscape.
- Professional channel sales decline as stylists shift to competing brands
- Retail distribution expansion offsets slowing direct-to-consumer organic growth
- Marketing spend increases to combat market share loss and competition
- Gross margins compress due to inventory write-downs and promotional activity
| Net Income: -15.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.51 > 1.0 |
| NWC/Revenue: 88.19% < 20% (prev 151.7%; Δ -63.52% < -1%) |
| CFO/TA 0.05 > 3% & CFO 69.1m > Net Income -15.0m |
| Net Debt (26.3m) to EBITDA (63.9m): 0.41 < 3 |
| Current Ratio: 6.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (669.9m) vs 12m ago 0.52% < -2% |
| Gross Margin: 64.93% > 18% (prev 0.66%; Δ 6.43k% > 0.5%) |
| Asset Turnover: 26.33% > 50% (prev 23.76%; Δ 2.57% > 0%) |
| Interest Coverage Ratio: 0.28 > 6 (EBITDA TTM 63.9m / Interest Expense TTM 35.5m) |
| A: 0.26 (Total Current Assets 446.3m - Total Current Liabilities 71.1m) / Total Assets 1.46b |
| B: 0.36 (Retained Earnings 531.4m / Total Assets 1.46b) |
| C: 0.01 (EBIT TTM 10.1m / Avg Total Assets 1.62b) |
| D: 0.91 (Book Value of Equity 531.9m / Total Liabilities 582.2m) |
| Altman-Z'' = 3.87 = AA |
| DSRI: 1.56 (Receivables 37.5m/23.8m, Revenue 425.4m/420.7m) |
| GMI: 1.02 (GM 64.93% / 65.97%) |
| AQI: 1.15 (AQ_t 0.69 / AQ_t-1 0.60) |
| SGI: 1.01 (Revenue 425.4m / 420.7m) |
| TATA: -0.06 (NI -15.0m - CFO 69.1m) / TA 1.46b) |
| Beneish M = -2.51 (Cap -4..+1) = A |
As of May 27, 2026, the stock is trading at USD 2.04 with a total of 4,144,698 shares traded.
Over the past week, the price has changed by +0.49%,
over one month by +0.99%,
over three months by +22.16% and
over the past year by +60.63%.
Olaplex Holdings has received a consensus analysts rating of 2.89. Therefore, it is recommended to hold OLPX.
- StrongBuy: 0
- Buy: 0
- Hold: 8
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 2 | -2.9% |
P/E Forward = 20.4499
P/S = 3.2389
P/B = 1.5653
Revenue TTM = 425.4m USD
EBIT TTM = 10.1m USD
EBITDA TTM = 63.9m USD
Long Term Debt = 352.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 352.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 26.3m USD (calculated: Debt 352.5m - CCE 326.2m)
Enterprise Value = 1.40b USD (1.38b + Debt 352.5m - CCE 326.2m)
Interest Coverage Ratio = 0.28 (Ebit TTM 10.1m / Interest Expense TTM 35.5m)
EV/FCF = 20.61x (Enterprise Value 1.40b / FCF TTM 68.1m)
FCF Yield = 4.85% (FCF TTM 68.1m / Enterprise Value 1.40b)
FCF Margin = 16.01% (FCF TTM 68.1m / Revenue TTM 425.4m)
Net Margin = -3.53% (Net Income TTM -15.0m / Revenue TTM 425.4m)
Gross Margin = 64.93% ((Revenue TTM 425.4m - Cost of Revenue TTM 149.2m) / Revenue TTM)
Gross Margin QoQ = 72.12% (prev 57.65%)
Tobins Q-Ratio = 0.96 (Enterprise Value 1.40b / Total Assets 1.46b)
Interest Expense / Debt = 10.09% (Interest Expense 35.5m / Debt 352.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = 7.97m (EBIT 10.1m * (1 - 21.00%))
Current Ratio = 6.27 (Total Current Assets 446.3m / Total Current Liabilities 71.1m)
Debt / Equity = 0.40 (Debt 352.5m / totalStockholderEquity, last quarter 878.0m)
Debt / EBITDA = 0.41 (Net Debt 26.3m / EBITDA 63.9m)
Debt / FCF = 0.39 (Net Debt 26.3m / FCF TTM 68.1m)
Total Stockholder Equity = 880.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.93% (Net Income -15.0m / Total Assets 1.46b)
RoE = -1.70% (Net Income TTM -15.0m / Total Stockholder Equity 880.1m)
RoCE = 0.82% (EBIT 10.1m / Capital Employed (Equity 880.1m + L.T.Debt 352.5m))
RoIC = 0.75% (NOPAT 7.97m / Invested Capital 1.06b)
WACC = 8.92% (E(1.38b)/V(1.73b) * Re(9.17%) + D(352.5m)/V(1.73b) * Rd(10.09%) * (1-Tc(0.21)))
Discount Rate = 9.17% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 33.33 | Cagr: 0.18%
[DCF] Terminal Value 70.97% ; FCFF base≈77.5m ; Y1≈68.0m ; Y5≈54.9m
[DCF] Fair Price = 1.16 (EV 805.3m - Net Debt 26.3m = Equity 779.0m / Shares 672.0m; r=8.92% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -95.56 | EPS CAGR: -40.93% | SUE: 1.21 | # QB: 1
Revenue Correlation: -81.86 | Revenue CAGR: -6.14% | SUE: 0.95 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.02 | Chg30d=N/A | Revisions=-20% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.03 | Chg30d=N/A | Revisions=-20% | Analysts=6
EPS current Year (2026-12-31): EPS=0.09 | Chg30d=-0.44% | Revisions=+20% | GrowthEPS=+12.5% | GrowthRev=+2.3%
EPS next Year (2027-12-31): EPS=0.10 | Chg30d=+0.10% | Revisions=+43% | GrowthEPS=+10.5% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: +43%